Why Low Toxicity and High Target Selectivity Matter in the Peptide Based Cancer Therapeutics Market Peptide Based Cancer Therapeutics Market: Technologies, Segments, and Regional Opportunities Through 2027
The peptide based cancer therapeutics market is gaining relevance in oncology as developers look for treatments that address the limitations of conventional cancer care. Polaris Market Research reports that the market was valued at USD 8.58 billion in 2019 and is expected to grow at a CAGR...
0 Shares
40 Views
0 Reviews